|
| Press Releases |
|
 |
|
| Tuesday, May 28, 2024 |
|
|
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project |
| German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders. The data resulting from this project have been acquired by Boehringer Ingelheim, where this research will be continued, potentially paving the way for novel therapies. more info >> |
|
| Thursday, May 16, 2024 |
|
|
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim |
| XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. more info >> |
|
| Tuesday, April 30, 2024 |
|
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg |
| BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to overcome the immunosuppressive microenvironment of solid tumors. more info >> |
|
| Tuesday, February 6, 2024 |
|
|
New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine |
| more info >> |
|
| Friday, December 22, 2023 |
|
|
BioMed X 研究所與小野藥品公司（Ono Pharmaceutical）在癌症研究領域啟動新的合作 |
| more info >> |
|
|
BioMed X 研究所与小野药品公司（Ono Pharmaceutical）在癌症研究领域启动新的合作 |
| more info >> |
|
|
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research |
| more info >> |
|
| Tuesday, November 7, 2023 |
|
|
BioMed X Launches a New Call for Application in Autoimmune Disease Research |
| more info >> |
|
| Wednesday, November 1, 2023 |
|
|
BioMed X and AbbVie Start New Research Project in the USA |
| more info >> |
|
| Thursday, June 29, 2023 |
|
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
| BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Shoucheng's Capital Leap: Zhao Tianyang Drives 2025 Upswing
Aug 1, 2025 14:50 HKT/SGT
|
|
|
Global Property Expo | Singapore 2025 attracts 2,500 Buyers With Intent, 40+ Exhibitors, with Projects spanning 20 Countries
Aug 1, 2025 14:48 HKT/SGT
|
|
|
国泰君安国际成功发行中资券商首笔公募数码原生债券
Aug 1, 2025 14:21 HKT/SGT
|
|
|
富士通、実用的な量子計算の実現に向けて、1万量子ビット超の超伝導量子コンピュータの研究開発を開始
Aug 1, 2025 10:30: JST
|
|
|
Honda Begins Joint Demonstration of Stationary Fuel Cell Power Station Designed to Utilize By-product Hydrogen and Repurposed Automotive Fuel Cells
Aug 1, 2025 11:20 JST
|
|
|
Isuzu's first battery-electric pickup "D-MAX EV" adopts eAxle
Aug 1, 2025 11:00 JST
|
|
|
A Bold New Chapter Begins at CEO SUITE
Aug 1, 2025 10:00 HKT/SGT
|
|
|
CEO SUITE開啟嶄新篇章
Aug 1, 2025 10:00 HKT/SGT
|
|
|
從黑馬投資人到產業引領者 趙天暘領銜首程控股迎來「投資豐收年」
Aug 1, 2025 09:40 HKT/SGT
|
|
|
从黑马投资人到资本引领者 赵天旸领衔首程控股开启“丰收年”
Aug 1, 2025 09:30 HKT/SGT
|
|
|
Fujitsu starts official development of plus-10,000 qubit superconducting quantum computer targeting completion in 2030
Aug 1, 2025 10:20 JST
|
|
|
Scipio Capital Advisors、資本調達により認定投資家にオルタナティブ資産の利回りを提供
Aug 1, 2025 09:00: JST
|
|
|
Scipio Capital Advisors 資本募集行動讓合格投資人觸及另類資產收益
Aug 1, 2025 08:00 HKT/SGT
|
|
|
GTJAI Successfully Issued the First Publicly Offered Digital Bond of a Chinese Securities Firm
Aug 1, 2025 00:00 HKT/SGT
|
|
|
國泰君安國際成功發行中資券商首筆公募數碼原生債券
Jul 31, 2025 23:50 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
